Cédric Lukas

4.8k total citations · 2 hit papers
112 papers, 3.3k citations indexed

About

Cédric Lukas is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Cédric Lukas has authored 112 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Rheumatology, 29 papers in Immunology and 28 papers in Hematology. Recurrent topics in Cédric Lukas's work include Rheumatoid Arthritis Research and Therapies (81 papers), Spondyloarthritis Studies and Treatments (41 papers) and Autoimmune and Inflammatory Disorders Research (28 papers). Cédric Lukas is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (81 papers), Spondyloarthritis Studies and Treatments (41 papers) and Autoimmune and Inflammatory Disorders Research (28 papers). Cédric Lukas collaborates with scholars based in France, Switzerland and Netherlands. Cédric Lukas's co-authors include Bernard Combe, Maxime Dougados, Jacques Morel, Désirée van der Heijde, Robert Landewé, Joseph M. Braun, Joachim Sieper, S van der Linden, John C. Davis and Thomas Barnetche and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Cédric Lukas

106 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

2008 720 citations Cédric Lukas, Maxime Dougados et al. Annals of the Rheumatic Diseases profile →
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

2006 566 citations Bernard Combe, Cédric Lukas et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Cédric Lukas

Since Specialization

Citations

This map shows the geographic impact of Cédric Lukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Lukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Lukas more than expected).

Fields of papers citing papers by Cédric Lukas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédric Lukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Lukas. The network helps show where Cédric Lukas may publish in the future.

Co-authorship network of co-authors of Cédric Lukas

This figure shows the co-authorship network connecting the top 25 collaborators of Cédric Lukas. A scholar is included among the top collaborators of Cédric Lukas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédric Lukas. Cédric Lukas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study 2025 ·ACR Open Rheumatology ·(unknown), Cédric Lukas, C. Daïen, C. Gaujoux-Viala, Laure Gossec, Anne‐Christine Rat, B. Combe, Jacques Morel	1
2	Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study 2024 ·RMD Open ·Maxime Dougados, Audrey Lardy-Cléaud, (unknown), Pascal Claudepierre, Philippe Goupille, (unknown), Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas	1
3	Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis 2024 ·RMD Open ·Sofía Ramiro, Cédric Lukas, Louis Bessette, (unknown), (unknown), Rebecca Bolce, Soyi Liu-Léage, (unknown), Michael J. Nissen, (unknown)	0
4	Sacroiliac joint MRI for diagnosis of ax-SpA: algorithm to improve the specificity of the current ASAS MRI criteria 2023 ·European Radiology ·(unknown), Cédric Lukas, (unknown), Mo Saffarini, (unknown), C. Cyteval	1
5	POS0970 PSYCHO-COGNITIVE FACTORS AND ADHERENCE IN AXIAL SPONDYLOARTHRITIS: A MULTICENTER CROSS-SECTIONAL STUDY 2023 ·Annals of the Rheumatic Diseases ·(unknown), Thomas Barnetche, (unknown), (unknown), Dana Jerome, (unknown), Cédric Lukas, Adeline Ruyssen‐Witrand, Anne Tournadre, Pascale Vergne‐Salle	1
6	MRI of sacroiliac joints for the diagnosis of axial SpA: prevalence of inflammatory and structural lesions in nulliparous, early postpartum and late postpartum women 2020 ·Annals of the Rheumatic Diseases ·(unknown), Cédric Lukas, (unknown), Patrice Taourel, Jean‐Baptiste Pialat, N. Sans, (unknown), C. Cyteval	26
7	Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort 2020 ·Arthritis Research & Therapy ·(unknown), Jacques Morel, Bernard Combe, Cédric Lukas	10
8	Optimization of ultrasonographic examination for the diagnosis of erosive Rheumatoid Arthritis in comparison to erosive hand Osteoarthritis 2019 ·European Journal of Radiology ·(unknown), Frédérique Gandjbakhch, A. Pierreisnard, Marion Couderc, Cédric Lukas, (unknown), (unknown), (unknown), Cédric Baumann, Isabelle Chary-Valckenaere, Damien Lœuille	2
9	Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort 2019 ·Arthritis Research & Therapy ·Gaël Mouterde, Nathalie Rincheval, Cédric Lukas, C. Daïen, Alain Saraux, Philippe Dieudé, Jacques Morel, Bernard Combe	24
10	Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review 2019 ·Arthritis Care & Research ·C. Rempenault, Bernard Combe, Thomas Barnetche, C. Gaujoux-Viala, Cédric Lukas, Jacques Morel, C. Hua	41
11	Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls 2017 ·PLoS ONE ·(unknown), Guilhem du Cailar, Rachel Audo, Cédric Lukas, Guillaume Vial, Anne Tournadre, (unknown), Jean Ribstein, Bernard Combe, Jacques Morel, C. Daïen	17
12	Prevalence and topographic distribution of spinal inflammation on MR imaging in patients recently diagnosed with axial spondyloarthritis 2016 ·Diagnostic and Interventional Imaging ·A. Larbi, (unknown), Cédric Lukas, (unknown), Nicolas Molinari, Patrice Taourel, C. Cyteval	8
13	Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort 2015 ·Arthritis Research & Therapy ·Rachel Audo, C. Daïen, Laura Papon, Cédric Lukas, Olivier Vittecoq, Michael Hahne, Bernard Combe, Jacques Morel	5
14	Association of Anticyclic Citrullinated Peptide Antibodies and/or Rheumatoid Factor Status and Clinical Presentation in Early Arthritis: Results from the ESPOIR Cohort 2014 ·The Journal of Rheumatology ·Gaël Mouterde, Cédric Lukas, Philippe Goupille, René‐Marc Flipo, Nathalie Rincheval, Jean‐Pierre Daurès, Bernard Combe	15
15	Assessment of MRI abnormalities of the sacroiliac joints and their ability to predict axial spondyloarthritis: a retrospective pilot study on 110 patients 2014 ·Skeletal Radiology ·A. Larbi, Pierre Viala, Nicolas Molinari, Cédric Lukas, (unknown), Patrice Taourel, C. Cyteval	13
16	Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis “ESPOIR” cohort 2014 ·Joint Bone Spine ·Ihsane Hmamouchi, Bernard Combe, Bruno Fautrel, Nathalie Rincheval, Cédric Lukas	14
17	Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort 2011 ·Annals of the Rheumatic Diseases ·Martin Soubrier, Cédric Lukas, Jean Sibilia, Bruno Fautrel, (unknown), Laure Gossec, (unknown), Maxime Dougados	61
18	PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort 2011 ·Lara D. Veeken ·Carine Salliot, (unknown), Cédric Lukas, Mickaël Guedj, Caroline Paccard, Joëlle Bénessiano, Maxime Dougados, Pascale Nicaise, Olivier Meyer, Philippe Dieudé	15
19	Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des Polyarthrites IndifféRenciées récentes (Study and Followup of Early Undifferentiate 2011 ·Arthritis & Rheumatism ·Cédric Lukas, Bernard Combe, Philippe Ravaud, Jean Sibilia, (unknown), D. van der Heijde	70
20	Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis 2011 ·Annals of the Rheumatic Diseases ·Gaël Mouterde, Cédric Lukas, I. Logeart, (unknown), Nathalie Rincheval, J.P. Daurès, Bernard Combe	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact